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During the course of studies on the effectiveness of Pneumococcus 
antigen under  different conditions,  unexpected  results were observed 
following the introduction of the bacteria into the skin.  It was found 
that the antibody response under this condition is strikingly different 
from that which is evoked by intravenous injection.  The response of 
the  animal to the intracutaneous  injection  of pneumococci has been 
subjected,  therefore, to a  thorough  study.  Some of the results have 
been  stated  in  a  preliminary  communication  (1).  Further  work  is 
reported  here. 
Methods 
1.  Preparation of Vaccines.  Eight to ten hour broth cultures of Pneumococcns 
were centrifuged at a high rate of speed, the supernatant fluid was discarded, and 
the organisms were suspended in an amount of saline solution equal to one-tenth of 
the  original  volume  of  culture.  Occasionally,  the  sedimented  bacteria  were 
washed 1 to 3 times before final resuspension.  The concentrated emulsion of bac- 
teria was then heated for one hour at 56-60°C.  and sterility was determined by 
cultures and intraperitoneal injection of white mice. 
g.  Preparation  of the Skin.  In the  earlier experiments the fur was removed 
by clipping and shaving, but later this was accomplished by gentle rubbing with a 
saturated solution of barium sulfite.  The latter method proved more satisfactory, 
since,  with care, it left a  perfectly clear skin which remained free of fur for a 
number of weeks.  The depilation was carried out on both sides of the body, and' 
since consecutive injections were made, it frequently became necessary to repeat 
the removal of fur. 
3. Method of Injection.  The suspensions of heat-killed pneumococci were injected 
intracutaneously once a week in quantities of 0.2 cc.  This amount was equivalent 
to 2.0 co. of the original culture.  The injections were given alternately on the two 
sides of the body, each injection being made in a different area of the skin.  The 
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number of injections in the different animals varied.  In the majority of instances, 
the total amount of suspension given was equivalent to 20 cc., or more, of culture. 
The results obtained, therefore, could be roughly compared with those observed 
following intravenous immunization of rabbits with similar amounts of culture. 
4. Testing  for Antibodies.  Some of the animals were tested for antibody produc- 
tion only after a complete series of ten injections and others at different intervals 
during the process.  Usually the rabbits were bled once a week, immediately pre- 
ceding each injection.  Final specimens of blood were procured 10 days following 
the last injection.  The sera were tested for the presence of type-specific anti- 
bodies (anti-S), which  agglutinate  the encapsulated, or S, cells  and precipitate 
the soluble specific substance derived from them, and also for species-specific anti- 
bodies  (anti-P  or anti-R)  which  agglutinate  only the  capsule-free, or R, cells 
and precipitate the protein derived from any type of Pneumococcus. 
EXPERIMENTAL 
Rabbits were injected into the skin with suspensions of heat-killed Pneumo- 
coccus Type I  or Type III, or an R strain derived from Type II Pneumococcus. 
In addition, intracutaneous injections were made with solutions of derivatives of 
Pneumococcus, one of which consisted essentially of a solution of "nucleoprotein" 
(2) and the other of the supernatant fluid after acid precipitation of the "nucleo- 
protein" from a solution of pneumococci resulting  from repeated freezing  and 
thawing.  The strain of Type I  Pneumococcus employed was virulent for white 
mice and rabbits, and killed animals of both species when 10 -7 cc. of culture was 
administered.  The Type III culture killed mice in a quantity of 10- ~ cc. of cul- 
ture, but did not kill rabbits in amounts as high as several cc., although in these 
animals it was capable of producing a transient septicemia.  In one experiment a 
rabbit-virulent strain of Type III Pneumococcus was used as antigen.  The lethal 
dose of this strain varied from 10 -3 to 10 .4 cc. of culture. 
Antibody Response to Type f  (S) Pneumococcus 
Several groups of rabbits  (sixty animals in all) were given repeated 
intracutaneous injections of suspensions Pneumococcus Type I.  The 
development of antibodies was essentially the same in all the animals 
so that for the sake of brevity and clarity,  one group will be described 
in detail as typical.  The data obtained in the study of this group are 
represented  graphically  in  Figure  1.  The  curves  for  the  develop- 
ment of type-specific and species-specific agglutinins were plotted from 
the averages of the titres of the sera of a group of four rabbits.  These 
rabbits had received 12 intracutaneous  injections of 0.2  cc. each of a 
suspension  of  heat-killed  pneumococci  of  Type  I  (S  form),  a  total 
number of bacteria equivalent to those contained in 24 cc. of culture, LOUIS A. ~-tILIANELLE  443 
which is more than the amount required for the usual intravenous 
immunization.  The  astonishing  result  was  the  absence  of  type- 
specific  agglutinins  and  type-specific precipitins in  the  sera  of  all 
the animals.  In other words, the sera did not cause the agglutina- 
tion of the bacteria employed in  the  immunization, nor precipitate 
the  soluble  specific substance  derived from them.  Moreover,  this 
result was obtained not only in this particular group of animals, but in 
a total of 60 rabbits receiving repeated intracutaneous inoculations of 
Type I  Pneumococcus only 7, or about 12 per cent, showed any evi- 
dence of type-specific response, and in these instances specific agglu- 
tinins were demonstrable only in low dilutions of the serum.  In two 
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Fiozree I. The development of antibodies  in rabbits  immunized intracuta- 
neously  to  Pneumococcus, Type L 
instances  agglutination  occurred in a dilution  of i:i,  in one instance 
1:3,  in three instances 1:5,  and in one case 1:20. Obviously, these 
results are in marked contrast to those obtained with the sera  of 
animals which have received similar  quantities  of  organisms adminis- 
tered intravenously, in which case agglutination usually occurs in 
dilutions  of  i:  80  to I:  160.  The  lack  of  type-specific  antibodies  can be 
interpreted  as  evidence  of  the  disintegration  of  the  type-specific  antigen 
after  the  introduction  of  the  intact  cell  into  the  skin. 
Despite the fact  that type-specific  (anti-S)  antibodies were absent, 
the spedes-spedfic antibodies (anti-P  or anti-R) were found to be 
present in  high degree  in  the sera  of all  the rabbits.  As illustrated  in 444  INTRACUTANEOUS  INJECTIONS  OF  PNEUMOCOCCI.  I 
Figure  1  the  species-specific antibodies,  as measured by the agglu- 
tination of R  cells, are definitely detectable after the third or fourth 
injection, and after about the sixth injection there is a  constant and 
rapid rise in titre which may reach a serum dilution of 1: 640.  In the 
sera of some rabbits,  not included in  the accompanying curves, the 
concentration of species-specific antibodies was even higher. 
Antibody Response to Type IfI (S) Pneumococcus 
In terms of its capacity to stimulate the formation of type-specific 
antibodies, Type In  Pneumococcus is at best a  poor antigen.  The 
recent work of Tillett (4) has established the fact that Type nI strains 
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FIGURE 2.  The development  of antibodies in  rabbits  immunized intracuta- 
neously to Pneumococcus,  Type III. 
of marked virulence for mice are usually not only avirulent for rabbits, 
but in only a  small percentage of rabbits  (15 per cent) do they elicit 
a  type-specific antigenic response following intravenous' inoculation. 
Moreover, his results indicate that with Type III Pneumococcus there 
is a  parallelism between type-specific antigenicity and virulence.  It 
was to  be expected, then,  that  rabbits  immunized intracutaneously 
with Type III pneumococci would respond very poorly in the produc- 
tion of type-specific antibodies. 
In  Figure  2,  curves  are  given  which illustrate the development 
of anti-S and anti-R agglutinins.  The rabbits were given 12 injections 
of 0.2 cc. each of a suspension of Type III pneumococci, thus receiving LOUIS  A.  JULIANELLE  445 
in all the equivalent of 24 cc. of culture.  It will be seen that at no 
time were type-specific antibodies demonstrable either as agglutinins 
or precipitins.  None of  a  total of  45  rabbits,  studied  at  different 
times, possessed anti-S antibodies  in  their  sera  during or following 
repeated intracutaneous injections of Type III pneumococci. 
On the other hand, in the sera of all the rabbits species-specific anti- 
bodies were demonstrable.  As Figure 2 illustrates, the development 
of anti-R agglutinins in these rabbits  closely parallels that observed 
in the group immunized intracutaneously to  suspensions of Type I 
pneumococci. 
Antibody Response to R Pneumococcus 
That R  organisms fail to incite the formation of type-specific anti- 
bodies has been the common experience of all workers.  The intra- 
venous administration  of R  cells  leads only to  the  development of 
species-specific antibodies.  In studying the antibody response in rab- 
bits following intracutaneous injections, an R strain derived from Type 
II was employed as antigen, and in each instance the total amount of 
heat-killed suspension employed was equivalent to at least 20 cc. of 
culture.  None of the rabbits immunized in this manner formed type- 
specific antibodies.  The serum of all the rabbits, however, contained 
species-specific  agglutinins  and  precipitins  in  titres  comparable  to 
those observed in rabbits immunized to Pneumococcus Type I  and 
Type III. 
The injection into the skin of the Pneumococcus cell, whether R  or 
S, elicits an antibody response which is essentially or entirely of the 
species-specific  variety.  It  seems  likely,  therefore,  that  the  type 
specificity of the S form is destroyed when it is introduced into the skin. 
Antibody Response to Soluble Derivatives of Pneumococcus 
In the preceding experiments rabbits were immunized by the inocu- 
lation of the intact, formed cells.  The  studies of  Reimann (5)  have 
revealed that  the  antigenic  response of animals  to  injection of the 
"nucleoprotein"  of  Pneumococcus  is identical with the  response to 
the intact R  cells.  It was interesting, therefore, to compare the anti- 
genie response of rabbits  to the  intracutaneous injections of soluble 
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of the intact cells.  The soluble derivatives were obtained from an S 
strain of Type II Pneumococcus.  The  cells were frozen and thawed 
repeatedly, and from the resulting solution of bacterial substance, by 
precipitation with acetic acid in the cold, a  material  designated  for 
convenience  as "nucleoprotein" (2) was obtained.  The residual super- 
natant  fluid,  after precipitation with acetic  acid,  was also  studied. 
This supernatant fluid contains, in addition to  other substances,  the 
purpura producing material of Pneumococcus (3, 6).  The two soluble 
derivatives were inoculated consecutively once a week into the skin of 
rabbits in a volume of 0.2 cc. each.  The substances were standardized 
on the basis of protein nitrogen, and rabbits received in toto at least 
70 mgm. of the first substance and at least 30 mgm. of the latter con- 
sidered as protein. 
As was  to  be  expected, none of the rabbits  injected with  either 
of these two soluble derivatives showed,anti-S in their sera.  This is in 
agreement with previous results  (7)  from this laboratory.  On  the 
other hand, all of the rabbits possessed precipitins for the "nucleo- 
protein" and agglutinins for the R  cells but in somewhat lower titre 
than that demonstrated in the sera of rabbits immunized by either the 
intact R or S forms of Pneumococcus. 
Antibody Response to Intravenous Injections  after Previous Intra- 
cutaneous Immunization 
The marked differences in antibody responses to  type-specific anti- 
gens, depending upon whether the intravenous or intracutaneous route 
of  administration  was  employed,  raised  the  question  whether the 
property of inducing disintegration or dissociation of the type-specific 
antigen is possessed only by certain tissues, such as the skin, or whether 
all tissues of the animal body are potentially able to induce this disinte- 
gration, and whether, as a result of repeated intracutaneous injections, 
this property might be so exalted that  subsequent intravenous intro- 
duction of the bacteria would fail to  elicit a  type-specific antibody 
response.  In  order  to  determine the  answer to  this  question  the 
following experiment was made.  Twelve  rabbits were selected which, 
following repeated intracutaneous immunization, did not show type- 
specific antibodies in their sera.  Six had been immunized  with a sus- 
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of Type III pneumococci.  All twelve were then immunized by intra- 
venous injections of a suspension of heat-killed Type I pneumococci. 
Following the intravenous immunization, the sera of all 12 rabbits were 
found to agglutinate Type I cells specifically.  The titre in each case 
reached as high as 1:160.  This titre is slightly higher than that usu- 
ally found in normal rabbits after intravenous immunizationalone. 
DISCUSSION 
The significant result of the present study is that the type-specific 
antigen of pneumococcus does not stimulate the production of anti- 
bodies when it is injected into the skin.  This is in marked contrast 
with the results obtained when the injections are made intravenously. 
Following intracutaneous injections of the whole organisms the result- 
ing antibodies are of the species-specific type.  While in the skin the 
type-specific substances ot the bacterial cell, therefore, become ineffec- 
five, the remaining constituents of the pneumococcal cell retain the 
power of stimulating antibody formation.  The antibody response to 
intracutaneous inoculations is the same whether the type-specific cells 
(S forms), the cells which do not possess  type-specific characters (R 
forms), or the soluble protein constituents of the cell are injected. 
Why the type specific antigen of the cell, when injected into the skin, 
becomes ineffective in stimulating antibody response is not entirely 
clear.  It is possible  that in the skin the bacteria are mechanically 
localized and that, as a result, the cells undergo a disintegration, com- 
parable  to  autolysis,  during which the type-specific antigen is  de- 
stroyed.  It is more likely that the skin possesses a peculiar property 
oi causing disintegration or dissociation of the compound type-specific 
antigen, so that the latter is no longer able to stimulate theproduction 
of antibodies. 
Similar failure of pneumococci to stimulate the production of type- 
specific antibodies when the bacteria are injected into the skin has been 
noted by others.  Goodner (8) found that when live virulent cultures 
of Type I pneumococci were injected into the skin of rabbits half of the 
animals failed to develop type-specific antibodies in their sera.  Gross 
(9) has also found that following the intracutaneous injections of small 
amounts of live pneumococci in rabbits, no agglutinins appeared in the 
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frequently failed to appear in the sera of animals after pneumococci 
had  been  instilled into  the  nose.  It  is  of much significance that 
in the experiments of these three sets of observers antibodies failed to 
develop following the injection of live virulent pneumococci, in two 
cases into the skin, and in the other case into the nose. 
SUMMARY AND C0NCLUSI0~S 
1.  Sixty rabbits were immunized by the repeated injections into the 
skin of small doses of suspensions of heat-killed Type I  pneumococci. 
In 53 of the rabbits no type-specific antibodies appeared in the serum, 
and in the remaining seven the titre of these antibodies in the serum 
was very low.  In all cases, however, the sera possessed a high titre of 
species-specific antibodies. 
2.  Forty-five rabbits  similarly immunized by  injections of heat- 
killed Type III pneumococci  also failed to form type-specific antibodies 
but did form species-specific antibodies. 
3.  Suspensions of heat-killed R  pneumococci and solutions of bac- 
terial substances when injected into the skin stimulated the production 
of species-specific antibodies, although they failed to  stimulate the 
production of any type-specific antibodies. 
4.  Animals which had been immunized  by intracutaneous injections 
still possessed the ability to form type-specific antibodies when they 
were  subsequently  given  intravenous  inoculations  of  type-specific 
pneumococci. 
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